Individualizing Calcineurin Inhibitor Therapy in Renal Transplantation - Current Limitations and Perspectives

E-ISSN： 1873-4286|16|2|176-186

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.2, 2010-01, pp. : 176-186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Calcineurin Inhibitor-Free Immunosuppression in Pediatric Renal Transplantation: A Viable Option?

By Höcker Britta Tönshoff Burkhard

Pediatric Drugs, Vol. 13, Iss. 1, 2011-02 ,pp. : 49-69

Adis International

Access to resources Recommend Favorite

Induction Therapy in Renal Transplantation: An Overview of Current Developments

By Ciancio Gaetano Burke George W. Miller Joshua

Drugs, Vol. 67, Iss. 18, 2007-01 ,pp. : 2667-2680

Adis International

Access to resources Recommend Favorite

Calcineurin Inhibitors in Renal Transplantation: What is the Best Option?

By Tanabe K.

Drugs, Vol. 63, Iss. 15, 2003-01 ,pp. : 1535-1548

Adis International

Access to resources Recommend Favorite

Economic Evaluations of Calcineurin Inhibitors in Renal Transplantation: A Literature Review

By Miners Alec H.

PharmacoEconomics, Vol. 25, Iss. 11, 2007-01 ,pp. : 935-947

Adis International

Access to resources Recommend Favorite

Evaluation of the novel protein kinase C inhibitor sotrastaurin as immunosuppressive therapy after renal transplantation

By Matz Mareen Naik Marcel Mashreghi Mir-Farzin Glander Petra Neumayer Hans-H Budde Klemens

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 1, 2011-01 ,pp. : 103-113

Informa Healthcare

Access to resources Recommend Favorite